Aspirin may lower the risk of pancreatic cancer

	Tweet

The use of aspirin at least once per month is associated with a significant decrease in pancreatic cancer risk, according to results of a large case-control study presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.

Xiang-Lin Tan, Ph.D., M.D., a research fellow at Mayo Clinic in Rochester, Minn., said the findings from this large collaborative study are preliminary and do not encourage widespread use of aspirin for this purpose.

“The results are not meant to suggest everyone should start taking aspirin once monthly to reduce their risk of pancreatic cancer,” said Tan. “Individuals should discuss use of aspirin with their physicians because the drug carries some side effects.”

For the current study, Tan and colleagues enrolled 904 patients who had documented pancreatic cancer and compared them with 1,224 healthy patients. All patients were at least 55 years old and reported their use of aspirin, NSAIDs and acetaminophen by questionnaire.

Results showed that people who took aspirin at least one day during a month had a 26 percent decreased risk of pancreatic cancer compared to those who did not take aspirin regularly. The effect was also found for those who took low-dose aspirin for heart disease prevention at 35 percent lower risk, according to Tan.

The researchers did not see a benefit from non-aspirin NSAIDs or acetaminophen. “This provides additional evidence that aspirin may have chemoprevention activity against pancreatic cancer,” said Tan. He added that more data must be gathered before we can prove a real benefit.

###

Press registration for the AACR 102nd Annual Meeting 2011 is free to qualified journalists and public information officers: http://www.aacr.org/PressRegistration

Follow the AACR on Twitter: @aacr #aacr
Follow the AACR on Facebook: http://www.facebook.com/aacr.org

The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 33,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowships and career development awards. The AACR Annual Meeting attracts more than 18,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. Including Cancer Discovery, the AACR publishes seven major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. AACR journals represented 20 percent of the market share of total citations in 2009. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists.

###

Contact: Jeremy Moore

267-646-0557
American Association for Cancer Research

RELATED STORIES:
What is a Neuroendocrine Tumor?   New research improves early detection and survival for pancreatic cancer   Some support for pancreatic cancer screening   Islet Cell Tumors (Endocrine Pancreas)   New Treatment for Pancreatic Cancer Allows Life-Saving Surgery   Naturally-occurring apple compounds reduce risk of pancreatic cancer   Pancreatic Cancer Expert at University of Virginia   Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy   Pancreatic Tumors Are Marked for Immunotherapy   Mayo Clinic Researchers Find Oncogene is Important in Pancreatic Cancer Growth and Spread   EGFR essential for the development of pancreatic cancer   Micro Molecules Can Identify Pancreatic Cancer   New drug achieves pancreatic cancer tumor remission and prevents recurrence   No support for routine pancreatic cancer screening   An Herbal Extract Inhibits the Development of Pancreatic Cancer   Sugary foods linked to pancreatic cancer risk   Gefitinib may have chemopreventive benefits in pancreatic cancer   Americans mixed on adequacy of cancer screenings: poll   Gene therapy tested in pancreatic cancer studies   Big belly raises a woman’s pancreatic cancer risk   Research Looks at Advanced Radiation for Pancreatic Cancer   A promising approach in the prevention and treatment of pancreatic cancer

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]